DrugId:  1
1. Name:  Cocarboxylase
2. Groups:  Approved, Experimental
3. Description:  The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the pyruvate dehydrogenase complex and the ketoglutarate dehydrogenase complex.
4. Indication:  Not Available
DrugId:  2
1. Name:  5-Methylpyrrole
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  3
1. Name:  1-Methyl-2-quinolone
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  4
1. Name:  Navicixizumab
2. Groups:  Investigational
3. Description:  Navicixizumab is under investigation in clinical trial NCT02298387 (A Phase 1 Study of Navicixizumab in Subjects With Solid Tumors).
4. Indication:  Not Available
DrugId:  5
1. Name:  5-Bromonicotinamide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  6
1. Name:  Arverapamil
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in irritable bowel syndrome (IBS) and diarrhea.
DrugId:  7
1. Name:  3-Chlorophenol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  8
1. Name:  Tartronate
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  9
1. Name:  4-methylumbelliferyl Î±-D-glucoside
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  10
1. Name:  HGTV-43
2. Groups:  Investigational
3. Description:  HGTV43 is an anti-sense treatment designed to produce T cells that are genetically resistant to HIV infection. HGTV43 is one of a number of so-called 'gene transfer vectors' developed by the biotechnology company Enzo Biochem, Inc.
4. Indication:  Investigated for use/treatment in HIV infection.
DrugId:  11
1. Name:  Ethanolamine
2. Groups:  Experimental
3. Description:  A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases. [PubChem]
4. Indication:  Not Available
DrugId:  12
1. Name:  Eleclazine
2. Groups:  Investigational
3. Description:  Eleclazine has been used in trials studying the treatment of LQT2 Syndrome, Long QT Syndrome, Ischemic Heart Disease, Ventricular Arrhythmia, and Long QT Syndrome Type 3, among others.
4. Indication:  Not Available
DrugId:  13
1. Name:  Tezacitabine
2. Groups:  Investigational
3. Description:  A synthetic purine nucleoside analogue with potential antineoplastic activity.
4. Indication:  Investigated for use/treatment in colorectal cancer, lung cancer, leukemia (unspecified), and gastric cancer.
DrugId:  14
1. Name:  Verdinexor
2. Groups:  Investigational
3. Description:  Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults).
4. Indication:  Not Available
DrugId:  15
1. Name:  Efalizumab
2. Groups:  Approved, Investigational
3. Description:  Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin.
4. Indication:  For the treatment of adult patients with moderate to severe chronic plaque psoriasis, who are candidates for phototherapy or systemic therapy.
DrugId:  16
1. Name:  Tucatinib
2. Groups:  Investigational
3. Description:  Tucatinib has been used in trials studying the treatment of HER2 Positive Breast Cancers and HER2 Positive Metastatic Breast Cancers.
4. Indication:  Not Available
DrugId:  17
1. Name:  Ozagrel
2. Groups:  Investigational
3. Description:  Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
4. Indication:  Not Available
DrugId:  18
1. Name:  CE-224535
2. Groups:  Investigational
3. Description:  CE-224535 has been used in trials studying the treatment of Osteoarthritis.
4. Indication:  Not Available
DrugId:  19
1. Name:  Relenopride
2. Groups:  Investigational
3. Description:  Relenopride has been used in trials studying the treatment of Chronic Idiopathic Constipation.
4. Indication:  Not Available
DrugId:  20
1. Name:  Amobarbital
2. Groups:  Approved, Illicit
3. Description:  A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
4. Indication:  Not Available
DrugId:  21
1. Name:  13-deoxydoxorubicin
2. Groups:  Investigational
3. Description:  GPX-100 is an anthracycline anticancer drug that belongs to the family of drugs called antitumor antibiotics.
4. Indication:  Investigated for use/treatment in breast cancer and cancer/tumors (unspecified).
DrugId:  22
1. Name:  Naproxcinod
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in pain (acute or chronic), inflammatory disorders (unspecified), osteoarthritis, and arthritis and arthritic pain.
DrugId:  23
1. Name:  Mitiglinide
2. Groups:  Approved, Investigational
3. Description:  Mitiglinide is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells.
4. Indication:  For the treatment of type 2 diabetes.
DrugId:  24
1. Name:  LFF-571
2. Groups:  Investigational
3. Description:  LFF571 has been used in trials studying the treatment of Moderate Clostridium Difficile Infection.
4. Indication:  Not Available
DrugId:  25
1. Name:  Technetium Tc-99m ciprofloxacin
2. Groups:  Investigational
3. Description:  99mTc-Ciprofloxacin is a new formulation of ciprofloxacin (INFECTON), being investigated as a radioimaging agent for the potential diagnosis of infection, including fever of unknown origin, osteomyelitis, wound infection, abdominal abscess, pneumonia, appendicitis and tuberculosis. INFECTON combines the widely used antibiotic, ciprofloxacin, with Technetium ((99m)Tc), the most commonly used radioisotope in nuclear medical imaging There is currently controversy around the drug's ability to discriminate between sterile inflammation and bacterial versus nonbacterial infections.
4. Indication:  Investigated for use/treatment in infectious and parasitic disease (unspecified).
